Skip to content
MedsAcross

Medicine

Glipizide 2.5 mg tablet

Glipizide · Oral
Available on requestPrescription onlyUS FDAGeneric name

Glipizide 2.5 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Glipizide
Brand
Sold under the generic name
Strength
2.5 mg
Dosage form
Tablet
Route
Oral
Packs
1000 tablets, 100 tablets, 500 tablets and 6 more
Manufacturers
Advagen PharmaAiPing PharmaceuticalTruPharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A10BB07 Glipizide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
3 October 2023
Identifiers
RxCUI 310488, 310490, 379804 +1DailyMed set ID e954afb8-52eb-416a-8f1b-14b0fcb3bac2, 95ea4c96-84b9-4515-9494-a93d26820f70, 2110a7ca-3c1f-4db4-9211-65546b74533cNDC 72888-115, 52817-385, 11788-120Application ANDA214874, ANDA074305

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1000 tablet in 1 bottle72888-115-00Advagen Pharma3 October 2023
100 tablet in 1 bottle72888-115-01Advagen Pharma3 October 2023
500 tablet in 1 bottle72888-115-05Advagen Pharma3 October 2023
30 tablet in 1 bottle72888-115-30Advagen Pharma3 October 2023
100 tablet in 1 bottle11788-120-01AiPing Pharmaceutical9 October 2026
500 tablet in 1 bottle11788-120-05AiPing Pharmaceutical9 October 2026
1000 tablet in 1 bottle11788-120-10AiPing Pharmaceutical9 October 2026
100 tablet in 1 bottle52817-385-10TruPharma3 October 2023
500 tablet in 1 bottle52817-385-50TruPharma3 October 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 May 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Glipizide

Clinical summary

Glipizide is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Glipizide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Glipizide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Glipizide 2.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.